XML 41 R27.htm IDEA: XBRL DOCUMENT v3.20.1
Common Stock and Stockholders' Equity (Tables)
12 Months Ended
Dec. 31, 2019
Equity [Abstract]  
Common Stock Reserved for Future Issuance
The following shares of common stock were reserved for future issuance as of December 31, 2019 (in thousands):
Class A-1 convertible preferred stock outstanding (as-converted)
4,159

Class A-2 convertible preferred stock outstanding (as-converted)
32,884

Initial Closing warrants
13,890

Milestone Closing warrants
32,884

Common stock options outstanding
3,098

RSUs outstanding
129

Common stock available for future grant under the 2019 Equity Incentive Plan
404

Employee Stock Purchase Plan
192

Total common shares reserved for future issuance
87,640

Stock Option Activity
The following table summarizes our stock option activity under all equity incentive plans for the year ended December 31, 2019 (shares and aggregate intrinsic value in thousands):
 
Number of
options
 
Weighted
average
exercise
price
 
Weighted average remaining contractual term
 
Aggregate intrinsic value
Options outstanding at December 31, 2018
59

 
$
45.60

 
 
 
 
Granted
3,224

 
$
0.68

 
 
 
 
Exercised
(3
)
 
$
0.95

 
 
 
 
Canceled/forfeited/expired
(182
)
 
$
6.81

 
 
 
 
Options outstanding at December 31, 2019
3,098

 
$
1.17

 
9.6
 
$
703

Exercisable at December 31, 2019
237

 
$
6.78

 
8.5
 
$
35

Schedule of Restricted Stock Units Activity
The following table summarizes our RSU activity under all equity incentive plans for the year ended December 31, 2019 (shares and aggregate intrinsic value in thousands): 
 
Number of
options
 
Weighted
average
grant date fair value
 
Weighted average remaining contractual term
 
Aggregate intrinsic value
RSUs outstanding at December 31, 2018
601

 
$
1.50

 
 
 
 
Granted
287

 
$
0.95

 
 
 
 
Vested
(559
)
 
$
1.27

 
 
 
 
Canceled/forfeited/expired
(200
)
 
$
1.34

 
 
 
 
RSUs outstanding at December 31, 2019
129

 
$
1.50

 
0.8
 
$
115

Assumptions Used to Estimate Fair Value of Stock Options and Performance Stock and Employee Stock Purchase Plan
The following table summarizes the weighted average assumptions used to estimate the fair value of stock options and performance stock awards granted to employees under our 2012 Equity Incentive Plan, 2015 Inducement Plan, 2019 Equity Incentive Plan and the shares purchasable under our Employee Stock Purchase Plan during the periods presented:
 
 
Year ended December 31,
 
2019
 
2018
Stock options
 
 
 
Risk-free interest rate
1.7
%
 
2.7
%
Volatility
94.6
%
 
87.8
%
Dividend yield

 

Expected term (years)
6.1

 
6.1

Performance stock options
 
Risk-free interest rate
2.6
%
 
2.7
%
Volatility
93.8
%
 
87.4
%
Dividend yield

 

Expected term (years)
6.1

 
5.7

Employee stock purchase plan shares
 
Risk-free interest rate
2.3
%
 
1.9
%
Volatility
110.5
%
 
100.6
%
Dividend yield

 

Expected term (years)
0.5

 
0.5

Stock-Based Compensation
The following table summarizes the allocation of our stock-based compensation expense for all stock awards during the periods presented (in thousands): 
 
Year ended December 31,
 
2019
 
2018
Research and development
$
309

 
$
2,256

General and administrative
1,979

 
3,184

Total
$
2,288

 
$
5,440